Island Pharmaceuticals Ltd - Exploring indication expansion

322 Views13 Mar 2026 06:00

Issuer-paid

SUMMARY

Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
The company announced on 9 March 2026 a strategic collaboration with Burnet Institute to expand development pathways for ISLA-101 and Galidesivir.
The company is looking to expand the indications where its drugs may show efficacy, including measles, chikungunya and Ross River virus.

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream